National Diabetes News

Real-world study reveals risks for kidney failure, death for adults with diabetes

Lower eGFRs were associated with higher likelihood of developing kidney failure and death among adults with diabetes, according to results of a real-world cohort study published in the Clinical Journal of the American Society of Nephrology.

The sleep switch that builds muscle, burns fat, and boosts brainpower

As every bodybuilder knows, a deep, restful sleep boosts levels of growth hormone to build strong muscle and bone and burn fat. And as every teenager should know, they won’t reach their full height potential without adequate growth hormone from a full night’s sleep.

Research Shows Benefits of Tirzepatide for Type 1 Diabetes and Obesity

New studies show that tirzepatide use in people with type 1 diabetes and overweight or obesity resulted in significant weight loss as well as marked improvements in A1C, time in range, and risk factors for heart and kidney disease. Though life-changing medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are only approved right now for type 2 diabetes, a growing body of evidence shows the potential benefits for people living with type 1 diabetes as well.

'Light-touch' EHR referral strategy connects patients with prediabetes to community-based diabetes prevention programs

A recent study tested whether a referral order inside the Epic electronic health record (EHR) could help primary care clinicians refer patients to community-based diabetes prevention programs (DPPs), an important public health strategy to reduce incident type 2 diabetes, and whether patients enrolled after referral.

MIND diet, 3 other lifestyle interventions may help reduce cognitive decline

As we age, we experience a number of changes in our bodies and how they operate, including the brain. It’s not uncommon for people to have problems remembering names or having a slower time making decisions as we get older, normally referred to as mild cognitive impairment (MCI). However, it is not common for these types of cognitive issues to have a negative impact on a person’s overall daily life.

What supplement labels say, versus what consumers think they mean

Consumers read common supplement label phrases as promises of disease prevention or treatment, according to University of Texas Southwestern Medical Center and Duke University Medical Center research. Dietary supplement use is higher in the U.S. than anywhere else in the world, with approximately 56% of adults taking at least one form of supplement. While the FDA has regulations in place that hold companies responsible for ensuring the safety of their products and accurate labeling, the FDA does not review most supplements for safety or effectiveness before they are marketed.